MedPath

ALUNBRIG 180 MG COMPRIMIDOS RECUBIERTOS CON PELICULA

ALUNBRIG 180 MG COMPRIMIDOS RECUBIERTOS CON PELICULA

Commercialized
Register Number

1181264010

Prescription Type

Diagnóstico Hospitalario

Authorization Date

Nov 28, 2019

Dosage Form

COMPRIMIDO RECUBIERTO CON PELÍCULA

Route: VÍA ORAL

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number1181264010
EMA Approved
Yes

Drug Classification

Generic
No
Orphan
No
Biosimilar
No
Commercialized
Yes
CIMA AEMPS Classification

INGREDIENTS (1)

BRIGATINIBActive
Quantity: 180 mg
Name: BRIGATINIB

ATC CLASSIFICATION (3)

L01E
L01ED
L01ED04

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.